EDUCATION
B.A. cum laude (Biological Basis of Behavior) 1985, University of Pennsylvania,
     College of Arts and Sciences
M.D. (Medicine) 1992, University of Pennsylvania, School of Medicine

 

POSTDOCTORAL TRAINING
Internship, 1993, University of New Mexico
Diplomate of the National Board of Medical Examiners, 1993, University of New Mexico,
     School of Medicine
Residency, 1995, University of New Mexico, School of Medicine
Diplomate in Internal Medicine, 1996, University of New Mexico, School of Medicine

 

PROFESSIONAL LICENSURE AND CERTIFICATION (by examination)
New Mexico # 93-400
DEA No. BS3746508
Diplomate, National Board of Medical Examiners, 1995
Board Certification, American Board of Internal Medicine, 1996
Fellow of the American College of Physicians, 2001



EMPLOYMENT

2009 - Present Adjunct Scientist, Lovelace Respiratory Research Institute, Albuquerque, NM
2007 - Present Staff, ABQ Health Partners, Albuquerque, NM
2003 - Present Associate Professor of Pharmacy, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM
2003 - Present Associate Clinical Professor, University of New Mexico School of Medicine, Albuquerque, NM
2001 - 2007 Co-Investigator, Lovelace Scientific Resources, Albuquerque, NM
2000 - Present Member of Research Administration, Lovelace Health Systems, Albuquerque, NM
2000 - Present Founder, Medical Director, and Chair of the Clinical Thrombosis Center, Lovelace Health Systems, Albuquerque, NM
1997 - 2000 Medical Director of the Anticoagulation Clinic, Lovelace Health Systems, Albuquerque, NM
1996 - 1999 Member Episodes of Care – Anticoagulation, Lovelace Health Systems, Albuquerque, NM
1996 - 2003 Assistant Clinical Professor, University of New Mexico School of Medicine, Albuquerque, NM
1995 - Present Member of Hospitalist Team – CUF, Staff - Internal Medicine, Lovelace Health Systems, Albuquerque, NM


PROFESSIONAL AFFILIATIONS
American College of Physicians
Greater Albuquerque Medical Association
American Medical Association
American Board of Internal Medicine
Wilderness Medical Society
Hellenic Medical Society
New Mexico Board of Medical Examiners
International Society of Thrombosis and Haemostasis
Anticoagulation Forum
Investigators Against Thromboembolism
National Experts Consensus Panel for Clinical Excellence in Thrombosis Management
American College of Chest Physicians
International Academy of Clinical and Applied Thrombosis/Haemostasis





REPRESENTATIVE PUBLICATIONS

  1. Anderson, F. A., H. Decousus, J. F. Bergmann, B. Chong, J. Froehlich, J. Johnson, A. Kakkar, G. Merli, M. Monreal, R. Pavenello, M. Pini, F. Piovella, A. C. Spyropoulos, A. G. G. Turpie, V. Tapson and R. Zotz for the IMPROVE Investigators: A Multinational Observational Cohort Study in Hospitalized Medical Patients of Practices in Prevention of Venous Thromboembolism and Clinical Outcomes: Findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE). Chest 132(3): 936-945, 2007.

     

  2. Dunn, A. S., A. C. Spyropoulos and A. G. G. Turpie: Bridging Therapy in Patients on Long-Term Oral Anticoagulants who Require Surgery: The Prospective Perioperative Enoxaparin Cohort Trial (PROSPECT). J. Thromb. Hameost. 5(11): 2211-2218, 2007.

     

  3. Hyers, T. M. and A. C. Spyropoulos for the INNOVATE Investigators: Community-Based Treatment of Venous Thromboembolism with a Low-Molecular-Weight Heparin and Warfarin. J. Thromb. Thrombolysis 24(3): 225-232, 2007.

     

  4. Karakitsos, D., T. Saranteas, J. Poulara, A. Spyropoulos and A. Karabines: Catheter-Related Thrombosis and Inferior Vena Cava Filter Implantation in a Patient in the Intensive Care Unit: The Role of Ultrasound Monitoring. Acta Anaesthesiol. Scand. 51(7): 961-962, 2007.

     

  5. Spyropoulos, A. C.: Investigational Treatments for Venous Thromboembolism. Expert Opin. Investig. Drugs 16(4): 431-440, 2007.

     

  6. Spyropoulos, A. C. and J. Lin: Direct Medical Costs of Venous Thromboembolism and Subsequent Hospital Readmission Rates: An Administrative Claims Analysis from 30 Managed Care Organizations. J. Manag. Care Pharm. 13(6): 475-486, 2007.

     

  7. Alikhan, R. and A. C. Spyropoulos: Epidemiology of Venous Thromboembolism in Cardiorespiratory and Infectious Disease. Am. J. Med. 121(11): 935-942, 2008.

     

  8. Deitelzweig, S. B., S. C. McKean, A. N. Amin, D. J. Brotman, A. K. Jaffer and A. C. Spyropoulos: Prevention of Venous Thromboembolism in the Orthopedic Surgery Patient. Cleve. Clin. J. Med. 75 Suppl. 3: S27-S36, 2008.

     

  9. Douketis, J. D., P. B. Berger, A. S. Dunn, A. K. Jaffer, A. C. Spyropoulos, R. C. Becker and J. Ansell: The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl.): 299S-339S, 2008.

     

  10. Garcia, D. and A. C. Spyropoulos: Update in the Treatment of Venous Thromboembolism. Semin. Respir. Crit. Care Med. 29(1): 40-46, 2008.

     

  11. Haas, S. and A. C. Spyropoulos: Primary Prevention of Venous Thromboembolism in Long-Term Care: Identifying and Managing the Risk. Clin. Appl. Thromb. Hemost. 14(2): 149-158, 2008.

     

  12. Jaffer, A. K., A. N. Amin, D. J. Brotman, S. B. Deitelzweig, S. C. McKean and A. C. Spyropoulos: Prevention of Venous Thromboembolism in the Hospitalized Medical Patient. Cleve. Clin. J. Med. 75 Suppl. 3: S7-S16, 2008.

     

  13. Spyropoulos, A. C.: Outpatient-Based Primary and Secondary Thromboprophylaxis with Low-Molecular-Weight Heparin. Clin. Appl. Thromb. Haemost. 14(1): 63-74, 2008.

     

  14. Spyropoulos, A. C., D. J. Brotman, A. N. Amin, S. B. Deitelzweig, A. K. Jaffer and S. C. McKean: Prevention of Venous Thromboembolism in the Cancer Surgery Patient. Clev. Clin. J. Med. 75 Suppl. 3: S17-S26, 2008.

     

  15. Spyropoulos, A. C. and J. D. Douketis: Guidelines for Antithrombotic Therpay: Periprocedural Management of Antithrombotic Therapy and Use of Bridging Anticoagulation. Int. Angiol. 27(4): 333-343, 2008.

     

  16. Spyropoulos, A. C., S. Magnuson and S. K. Koh: The Use of Fondaparinux for the Treatment of Venous Thromboembolism in a Patient with Heparin-Induced Thombocytopenia and Thrombosis Caused by Heparin Flushes. Ther. Clin. Risk Manag. 4(3): 653-657, 2008.

     

  17. Spyropoulos, A. C., A. G. Turpie, A. S. Dunn, S. Kaatz, J. Douketis, A. Jacobson, H. Petersen and REGIMEN Investigators: Perioperative Bridging Therapy with Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients with Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry). Am. J. Cardiol. 102(7): 883-889, 2008.